
### [MONDO:0019218](http://purl.obolibrary.org/obo/MONDO_0019218)
**Label:** disorder of bile acid synthesis

**Subclasses:** [MONDO:0018841](http://purl.obolibrary.org/obo/MONDO_0018841) (congenital bile acid synthesis defect), [MONDO:0015581](http://purl.obolibrary.org/obo/MONDO_0015581) (bile acid synthesis defect with cholestasis and malabsorption), [MONDO:0008967](http://purl.obolibrary.org/obo/MONDO_0008967) (congenital bile acid synthesis defect 4), 

**Corr. equiv. classes:** [Orphanet:163631](http://www.orpha.net/ORDO/Orphanet_163631), [Orphanet:485631](http://www.orpha.net/ORDO/Orphanet_485631), [Orphanet:79095](http://www.orpha.net/ORDO/Orphanet_79095), [OMIM:214950](http://purl.obolibrary.org/obo/OMIM_214950), 

**Class expressions from DL-Learner:**

- [HP:0200084](http://purl.obolibrary.org/obo/HP_0200084) (Giant cell hepatitis) 62.50%
- [HP:0006579](http://purl.obolibrary.org/obo/HP_0006579) (Prolonged neonatal jaundice) and [HP:0200084](http://purl.obolibrary.org/obo/HP_0200084) (Giant cell hepatitis) 62.50%
- [HP:0006579](http://purl.obolibrary.org/obo/HP_0006579) (Prolonged neonatal jaundice) and [HP:0025155](http://purl.obolibrary.org/obo/HP_0025155) (Abnormality of hepatobiliary system physiology) 62.50%
- [HP:0006579](http://purl.obolibrary.org/obo/HP_0006579) (Prolonged neonatal jaundice) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 62.50%
- [HP:0006579](http://purl.obolibrary.org/obo/HP_0006579) (Prolonged neonatal jaundice) and [HP:0012115](http://purl.obolibrary.org/obo/HP_0012115) (Hepatitis) 62.50%
- [HP:0004325](http://purl.obolibrary.org/obo/HP_0004325) (Decreased body weight) and [HP:0006579](http://purl.obolibrary.org/obo/HP_0006579) (Prolonged neonatal jaundice) 62.50%
- [HP:0004323](http://purl.obolibrary.org/obo/HP_0004323) (Abnormality of body weight) and [HP:0006579](http://purl.obolibrary.org/obo/HP_0006579) (Prolonged neonatal jaundice) 62.50%
- [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) and [HP:0006579](http://purl.obolibrary.org/obo/HP_0006579) (Prolonged neonatal jaundice) 62.50%
- [HP:0003623](http://purl.obolibrary.org/obo/HP_0003623) (Neonatal onset) and [HP:0200084](http://purl.obolibrary.org/obo/HP_0200084) (Giant cell hepatitis) 62.50%
- [HP:0003623](http://purl.obolibrary.org/obo/HP_0003623) (Neonatal onset) and [HP:0025155](http://purl.obolibrary.org/obo/HP_0025155) (Abnormality of hepatobiliary system physiology) 62.50%
- [HP:0003623](http://purl.obolibrary.org/obo/HP_0003623) (Neonatal onset) and [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) 62.50%
- [HP:0003623](http://purl.obolibrary.org/obo/HP_0003623) (Neonatal onset) and [HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract) 62.50%
- [HP:0003623](http://purl.obolibrary.org/obo/HP_0003623) (Neonatal onset) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 62.50%
- [HP:0003623](http://purl.obolibrary.org/obo/HP_0003623) (Neonatal onset) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 62.50%
- [HP:0003623](http://purl.obolibrary.org/obo/HP_0003623) (Neonatal onset) and [HP:0012115](http://purl.obolibrary.org/obo/HP_0012115) (Hepatitis) 62.50%


